Form 4 for CRVL CORVEL CORP
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001754499-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-22 | 2024-02-20+ | CRVL | O'Brien Brandon | CFO | F - Tax | $255.40 | -1,881 | 7,299 | -20% | -$480.4K |
| DM | 2024-02-22 | 2024-02-21 | CRVL | O'Brien Brandon | CFO | S - Sale+OE | $260.00 | -813 | 7,299 | -10% | -$211.4K |
| DM | 2024-02-22 | 2024-02-20+ | CRVL | O'Brien Brandon | CFO | M - OptEx | $83.52 | +4,013 | 8,203 | +96% | +$335.2K |
| DM | 2024-02-22 | 2024-02-20+ | CRVL | O'Brien Brandon | CFO | M - OptEx | $203.56 | -4,013 | 4,800 | -46% | -$816.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | F | D | 504 | $260.89 | 7,699 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-21 | S | D | 375 | $260.00 | 7,299 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-21 | M | A | 375 | $52.69 | 7,674 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-21 | S | D | 438 | $260.00 | 7,299 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-21 | M | A | 438 | $79.49 | 7,737 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-20 | M | A | 1,700 | $87.69 | 7,680 | D | — | — | |
| 7 | Common | Common Stock | 2024-02-20 | F | D | 595 | $250.32 | 7,085 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-20 | F | D | 382 | $250.32 | 6,703 | D | — | — | |
| 9 | Common | Common Stock | 2024-02-21 | M | A | 1,500 | $87.69 | 8,203 | D | — | — | |
| 10 | Common | Common Stock | 2024-02-21 | F | D | 400 | $260.89 | 7,299 | D | — | — | |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-21 | M | D | 375 | $0.00 | 25 | D | $52.69 · — to 2025-04-30 | 375 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-21 | M | D | 1,500 | $260.89 | 3,300 | D | $87.69 · — to 2025-11-05 | 1,500 Common Stock | (F3) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-21 | M | D | 438 | $0.00 | 62 | D | $79.49 · — to 2025-07-31 | 438 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-20 | M | D | 1,700 | $250.32 | 4,800 | D | $87.69 · — to 2025-11-05 | 1,700 Common Stock | (F3) Option will vest based on achievement of certain performance criteria relating to earnings growth. |